Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CELL IMPACT AB | ICLA | Sep 27, 2024 | 0.01 | -45.00 |
CellaVision | C26 | Sep 27, 2024 | 24.95 | +1.84 |
Cellcom Israel Limited | F5U | Sep 27, 2024 | 3.84 | -8.57 |
Celldex Therapeutics, Inc. | TCE2 | Sep 27, 2024 | 29.20 | -9.88 |
Cellectar Biosciences | NV4 | Sep 27, 2024 | 1.66 | -1.19 |
Cellectis | ZVA | Sep 27, 2024 | 1.87 | +1.30 |
Cellectis S.A. - American Depositary Shares | ZVAA | Sep 27, 2024 | 1.87 | 0.00 |
CELLINK B | 49Z | Sep 27, 2024 | 4.00 | +8.99 |
Cellnex Telecom S.A. | 472 | Sep 27, 2024 | 36.44 | -0.05 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Sep 27, 2024 | 17.40 | 0.00 |
Cellular Goods Plc | 6XS | Sep 27, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Sep 27, 2024 | 6.14 | -1.44 |
Celsion Corporation | CBO | Sep 27, 2024 | 0.89 | -0.56 |
Celsius Resources Limited | FX8 | Sep 27, 2024 | 0.01 | 0.00 |
Celtic plc | CCP | Sep 27, 2024 | 1.94 | 0.00 |
Celyad Oncology | 1C0 | Sep 27, 2024 | 0.23 | -0.86 |
Cemat | 1X9 | Sep 27, 2024 | 0.14 | -0.37 |
CEMBRE S.P.A. EO 0,52 | J0L | Sep 27, 2024 | 37.05 | 0.00 |
Cementir Holding N.V. | 3PC | Sep 27, 2024 | 9.77 | +1.24 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | Sep 27, 2024 | 5.10 | 0.00 |
Cemex S.A.B. De C.V. | CEXA | Sep 27, 2024 | 5.70 | 0.00 |
Cemex S.A.B. De C.V. CPO | CEXB | Sep 27, 2024 | 0.56 | -5.08 |
Cenergy Holdings | 9CN | Sep 27, 2024 | 9.69 | +2.65 |
Cenit AG | CSH | Sep 27, 2024 | 11.40 | +2.70 |
Cenovus Energy Inc | CXD | Sep 27, 2024 | 14.47 | -2.08 |
Cenovus Energy Inc PRF PERPETUAL CAD - Ser 1 | CXD0 | Sep 27, 2024 | 11.10 | -1.77 |
CENOVUS ENERGY PFD SR.2 | CXD1 | Sep 27, 2024 | 11.50 | -0.86 |
CENOVUS ENERGY PFD SR.5 | CXD2 | Sep 27, 2024 | 14.60 | -0.68 |
CENOVUS ENERGY PFD SR.7 | CXD3 | Sep 27, 2024 | 14.50 | -0.68 |
Centamin PLC | 7CT | Sep 27, 2024 | 1.86 | -0.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.